Ieq Capital LLC Takes $42.74 Million Position in Synopsys, Inc. $SNPS

Key Points

• Ieq Capital LLC acquired 95,821 Synopsys shares worth approximately $42.74 million during the second quarter, giving the fund about a 0.05% stake. Institutional investors collectively own 85.47% of the company.
• Analysts maintain a generally favorable outlook, with Synopsys receiving a “Moderate Buy” consensus rating and an average price target of $563.59. Recent target increases included Bank of America’s move to $600 and Berenberg’s $633 target.
• Synopsys exceeded quarterly expectations, reporting $3.35 in adjusted EPS and $2.28 billion in revenue, up 41.9% year over year. CEO Sassine Ghazi and CFO Shelagh Glaser sold shares under pre-arranged Rule 10b5-1 plans, with the CEO’s sale also covering tax obligations tied to vested equity awards.

Ieq Capital LLC bought a new position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 95,821 shares of the semiconductor company's stock, valued at approximately $42,742,000. Ieq Capital LLC owned about 0.05% of Synopsys at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Sankala Group LLC bought a new stake in Synopsys in the 4th quarter worth approximately $25,000. Elevation Wealth Partners LLC boosted its position in shares of Synopsys by 96.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company's stock valued at $25,000 after acquiring an additional 27 shares during the last quarter. IMG Wealth Management Inc. bought a new position in shares of Synopsys during the 2nd quarter valued at approximately $28,000. Caitong International Asset Management Co. Ltd purchased a new position in shares of Synopsys in the fourth quarter valued at $28,000. Finally, Atlas Capital Advisors Inc. purchased a new position in shares of Synopsys in the fourth quarter valued at $32,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. Berenberg Bank set a $633.00 price target on shares of Synopsys in a research note on Wednesday, May 27th. Benchmark reissued a "buy" rating on shares of Synopsys in a research note on Wednesday. BNP Paribas Exane upped their target price on shares of Synopsys from $425.00 to $450.00 and gave the company an "underperform" rating in a research report on Thursday, May 28th. Needham & Company LLC reaffirmed a "buy" rating and issued a $580.00 price target on shares of Synopsys in a report on Thursday, May 28th. Finally, Bank of America lifted their price target on Synopsys from $515.00 to $600.00 and gave the stock a "buy" rating in a research report on Thursday, May 28th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $563.59.

Insider Activity at Synopsys

In related news, CFO Shelagh Glaser sold 3,394 shares of the firm's stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the sale, the chief financial officer directly owned 14,358 shares of the company's stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the business's stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the transaction, the chief executive officer owned 75,020 shares of the company's stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Corporate insiders own 0.56% of the company's stock.

Synopsys Price Performance

SNPS stock opened at $397.87 on Friday. The stock has a market cap of $76.18 billion, a PE ratio of 92.10, a P/E/G ratio of 2.34 and a beta of 1.23. Synopsys, Inc. has a 12 month low of $366.00 and a 12 month high of $615.79. The company has a 50-day moving average price of $419.73 and a 200 day moving average price of $440.22. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33.

Synopsys (NASDAQ:SNPS - Get Free Report) last posted its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping analysts' consensus estimates of $3.15 by $0.20. The company had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The firm's revenue for the quarter was up 41.9% on a year-over-year basis. During the same period in the prior year, the company posted $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities research analysts anticipate that Synopsys, Inc. will post 10.65 earnings per share for the current year.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source